Showing results (161-170 of 195) with videos related to
Sort By:
Pageof 20
Cancer Research|August 18, 2004
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancerZhen Zhang, Robert C Bast, Yinhua Yu, et al.Urologic Oncology|September 21, 2023
Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancerNeal D Shore, Dmitry M Polikarpov, Christopher M Pieczonka, et al.Clinical Chemistry|November 6, 2007
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample biasDale McLerran, William E Grizzle, Ziding Feng, et al.Clinical Chemistry|November 21, 2007
SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancerDale McLerran, William E Grizzle, Ziding Feng, et al.Nature Communications|August 23, 2017
Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometryBen C Collins, Christie L Hunter, Yansheng Liu, et al.Cell|May 15, 2012
Species-dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortexKenneth Y Kwan, Mandy M S Lam, Matthew B Johnson, et al.Clinical Chemistry and Laboratory Medicine|November 24, 2004
Multicentre performance evaluation of the E170 module for modular analyticsChristian Bieglmayer, Daniel W Chan, Lori Sokoll, et al.Journal of Proteome Research|November 11, 2017
Quality Assessments of Long-Term Quantitative Proteomic Analysis of Breast Cancer Xenograft TissuesJian-Ying Zhou, Lijun Chen, Bai Zhang, et al.Clinical Chemistry|December 23, 2004
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibilityO John Semmes, Ziding Feng, Bao-Ling Adam, et al.Clinical Chemistry|December 2, 2008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancersCatharine M Sturgeon, Michael J Duffy, Ulf-Håkan Stenman, et al.Pageof 20